Geron reported $198.42M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US $ 59196M 1969M
Bio Techne TECH:US $ 2299.89M 4.95M
Cti Biopharma CTIC:US $ 131.44M 59M
Cytokinetics CYTK:US $ 856.25M 14.93M
Esperion Therapeutics ESPR:US $ 342.85M 38.74M
Exelixis EXEL:US $ 2654.12M 37.88M
Genmab GEN:DC DK 24914M 287M
Geron GERN:US $ 198.42M 27.61M
Gilead Sciences GILD:US $ 63080M 4872M
Macrogenics MGNX:US $ 271.44M 63.8M
Novartis NOVN:VX SF 125218M 6577M
Novavax NVAX:US $ 2834.88M 258.12M
Pain Therapeutics PTIE:US $ 244.19M 22.59M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
YTE INCY:US $ 5054.22M 120.87M